I hear you, doc. The article states that he will develop 4 biotech SPACS, including a focus on cancer and immunotherapy. The IPOE/SOFI relationship seems to have worked well. Chamath brought SOFI public and Anthony Noto, CEO of SOFI is well-respected. This level of financial engineering is over my head, but I threw out the suggestion to the board because mgmt. needs help. As the saying goes, "they brought a knife to a gunfight".